Axsome Therapeutics, Inc.
NASDAQ:AXSM · NASDAQ Global Market
+$0.25 today
Vol 0.71M · Avg 0.72M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+146.43%
Period High
$255.17
Period Low
$100.39
Latest
$250.50
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Jazz Pharmaceuticals plc
NASDAQ:JAZZ
$14.26B
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
$11.42B
Cytokinetics, Incorporated
NASDAQ:CYTK
$9.72B
Nuvalent, Inc.
NASDAQ:NUVL
$9.07B
Metsera, Inc.
MTSR
$7.43B
Vaxcyte, Inc.
NASDAQ:PCVX
$7.32B
Merus N.V.
MRUS
$6.83B
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
$6.57B
Abivax S.A.
NASDAQ:ABVX
$6.57B
CRISPR Therapeutics AG
NASDAQ:CRSP
$5.12B
What is the latest AXSM filing?
The latest filing shown is 4 dated Jun 11, 2026.
How many recent filings does AXSM have?
Intrinsic Alpha currently shows 20 recent filings for AXSM.
Explore More
Continue the stock analysis
Jump to another research area for this company.